September 18, 2017
Egalet signs on as official sponsor for National Lacrosse League

Participating in this sponsorship deal:

Egalet logo Data?1415810039
Read More
The National Lacrosse League (NLL), the largest men’s professional indoor lacrosse league in North America, and Egalet Corporation (Nasdaq: EGLT), a specialty pharmaceutical company focused on developing innovative treatments for pain and other conditions, today announced a partnership focused on physician education around responsible pain management. The two-year agreement will include a product symposium at the 2017 NLL Medical Summit to educate physicians on how to help treat pain with a nonsteroidal anti-inflammatory drug (NSAID), which is also a non-narcotic pain management option. Egalet’s product SPRIX® (ketorolac tromethamine) Nasal Spray, is an NSAID approved in the United States for the short term (up to 5 days) management of moderate to moderately severe pain in adults that requires analgesia at the opioid level.
Read more at »
Comparable Deals
Nearby Deals

View cost of comparable deals

Signup as Professional
Deal Analysis

View Deal Details

Signup as Professional

View Deal Makers

Signup as Professional